Literature DB >> 15763335

Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.

Harel Dahari1, Anna Feliu, Montserrat Garcia-Retortillo, Xavier Forns, Avidan U Neumann.   

Abstract

BACKGROUND/AIMS: The existence of an extrahepatic hepatitis C virus replication compartment is an important question for optimizing therapy and preventing the infection of liver grafts. An extraheptic replication compartment could be indicated if viral decline during the anhepatic phase is not a single exponential. However, the duration of the anhepatic phase is too short (0.5-2h) to allow such analysis. Here we mathematically analyze viral decline during liver transplantation beyond the period of the anhepatic phase and examine the possibility of viral compartmentalization.
METHODS: Viral load of 30 patients undergoing liver transplantation was frequently measured. Simulation and non-linear fitting of differential equation models were used to test different compartmentalization hypotheses.
RESULTS: In 16 of the patients (56%), a bi-phasic viral decline was observed which is explained by the existence of a second replication compartment. This extrahepatic compartment is responsible for about 3.1% of virus in circulation and the mean half-life of its infected cells is 2.6 days. The remaining patients, with a single exponential decline, have either a second compartment with relatively low contribution or no second compartment.
CONCLUSIONS: These results provide a first quantitative picture of the extrahepatic hepatitis C viral contribution and may suggest new approaches for viral clearance.

Entities:  

Mesh:

Year:  2005        PMID: 15763335     DOI: 10.1016/j.jhep.2004.12.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  28 in total

Review 1.  Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.

Authors:  Juan-Ramón Larrubia; Elia Moreno-Cubero; Joaquín Miquel; Eduardo Sanz-de-Villalobos
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia.

Authors:  D Sansonno; F A Tucci; G Lauletta; V De Re; M Montrone; L Troiani; L Sansonno; F Dammacco
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 3.  Neurological complications of hepatitis C infection.

Authors:  Micheline McCarthy; Melissa R Ortega
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

4.  Hepatitis C virus and peripheral blood mononuclear cell reservoirs Patricia Baré.

Authors:  Patricia Baré
Journal:  World J Hepatol       Date:  2009-10-31

5.  Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells.

Authors:  Harel Dahari; Ruy M Ribeiro; Charles M Rice; Alan S Perelson
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

6.  Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation.

Authors:  Hui Li; Daniel G Sullivan; Nathan Feuerborn; Susan McArdle; Kirubeal Bekele; Sampa Pal; Matthew Yeh; Robert L Carithers; James D Perkins; David R Gretch
Journal:  Virology       Date:  2010-04-18       Impact factor: 3.616

7.  Hepatitis C Viral Kinetics in Special Populations.

Authors:  Harel Dahari; Jennifer E Layden-Almer; Alan S Perelson; Thomas J Layden
Journal:  Curr Hepat Rep       Date:  2008

8.  ANALYSIS OF HEPATITIS C VIRUS INFECTION MODELS WITH HEPATOCYTE HOMEOSTASIS.

Authors:  Timothy C Reluga; Harel Dahari; Alan S Perelson
Journal:  SIAM J Appl Math       Date:  2009-01-14       Impact factor: 2.080

9.  Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy.

Authors:  Harel Dahari; Arthur Lo; Ruy M Ribeiro; Alan S Perelson
Journal:  J Theor Biol       Date:  2007-03-14       Impact factor: 2.691

Review 10.  Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Authors:  Alberto Grassi; Giorgio Ballardini
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.